Literature DB >> 165853

Neuropathy in latent hereditary hepatic porphyria.

P Mustajoki, A M Seppălăinen.   

Abstract

Peripheral nerve conduction velocoties were measured in 20 patients with acute intermittent porphyria and five with variegate porphyria and in 25 controls matched for age and sex. None of the porphyric patients had acute symptoms on examination, and nine had never had symptoms. Compared with the controls, patients had a significantly slower conduction velocity of the slower motor fibres of the ulnar nerve (P less than 0-001) and a slower sensory conduction velocity of the ulnar and median nerves (P less than 0-05). There was no significant difference between the patients and controls in the maximum motor conductionvelocity of the median, ulnar, deep peroneal, or posterior tibial nerves. Slight peripheral neuropathy seems to be associated with latent hereditary hepatic porphyria, even in patients who have never had symptoms.

Entities:  

Mesh:

Year:  1975        PMID: 165853      PMCID: PMC1681914          DOI: 10.1136/bmj.2.5966.310

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  THE RELATIONSHIP OF LEAD POISONING TO ACUTE INTERMITTENT PORPHYRIA.

Authors:  J H DAGG; A GOLDBERG; A LOCHHEAD; J A SMITH
Journal:  Q J Med       Date:  1965-04

2.  Acute intermittent porphyria: a study of 50 cases.

Authors:  A GOLDBERG
Journal:  Q J Med       Date:  1959-04

3.  An investigation of porphyria cutanea tarda.

Authors:  G HOLTI; C RIMINGTON; B C TATE; G THOMAS
Journal:  Q J Med       Date:  1958-01

4.  The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine.

Authors:  D MAUZERALL; S GRANICK
Journal:  J Biol Chem       Date:  1956-03       Impact factor: 5.157

5.  Effect of hematin in acute porphyric relapse.

Authors:  C J Watson; G J Dhar; I Bossenmaier; R Cardinal; Z J Petryka
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

Review 6.  Significance of the porphyrin precursors delta-aminolaevulinic acid (ALA) and porphobilinogen (PBG) in the acute attack of porphyria.

Authors:  S Kramer; D Becker; D Viljoen
Journal:  S Afr Med J       Date:  1973-09-29
  6 in total
  9 in total

1.  Free erythrocyte protoporphyrin level and nerve conduction velocity in end-stage renal disease.

Authors:  G M London; Y Nordmann; M E Safar; S Métral; P Milliez
Journal:  Br Med J       Date:  1975-11-08

2.  Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria.

Authors:  R L Lindberg; R Martini; M Baumgartner; B Erne; J Borg; J Zielasek; K Ricker; A Steck; K V Toyka; U A Meyer
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Hereditary coproporphyria: unusual nervous system involvement in two cases.

Authors:  C Casali; M Lo Monaco; L D'Alessandro; D Griso; A Amantea; G C Topi; P Tonali
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

4.  Autonomic neuropathy in acute intermittent porphyria.

Authors:  A C Laiwah; G J Macphee; P Boyle; M R Moore; A Goldberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

5.  [Biochemical examinations and measurements of conduction velocity of trichloroethylene exposed persons (author's transl)].

Authors:  G Triebig; T Reichenbach; K A Flügel
Journal:  Int Arch Occup Environ Health       Date:  1978-09-15       Impact factor: 3.015

6.  Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic target.

Authors:  Aida Habtezion; Raymond Kwan; Alice L Yang; Maureen E Morgan; Ehsaan Akhtar; Stephen P Wanaski; Stephen D Collins; Eugene C Butcher; Ahmad Kamal; M Bishr Omary
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-21       Impact factor: 4.052

7.  Delta-Aminolaevulinic acid and amino acid neurotransmitters.

Authors:  M J Brennan; R C Cantrill
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

8.  Electromyogram and nerve conduction in patients with acute intermittent porphyria.

Authors:  K A Flügel; K F Druschky
Journal:  J Neurol       Date:  1977-03-21       Impact factor: 4.849

9.  Pathogenesis and treatment of acute intermittent porphyria: discussion paper.

Authors:  A C Laiwah; A Goldberg; M R Moore
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.